Abstract:Background: Previous studies have shown that necroptosis-related long noncoding RNA (lncRNA) risk models can be used to predict prognosis and immune infiltration in patients with esophageal cancer. However, further analysis of the regulatory mechanisms of necroptosis-related lncRNAs used in risk models remains to be conducted. The purpose of the present study was to identify valuable necroptosis-related lncRNAs in esophageal cancer and to verify their molecular and cellular functions. Methods: Esophageal cancer data were downloaded from The Cancer Genome Atlas (TCGA). The expression of eight genes (LINC00299, AC090912.2, AC244197.2, AL158166.1, AC079684.1, AP003696.1, AC079684.1 and AP003696.1) in the necroptosis-related lncRNA risk model, their relationships with clinicopathological stage, and their diagnostic receiver operating characteristic (ROC) curves were analyzed. The prognostic value of these lncRNAs for overall survival (OS) and disease specific survival (DSS) was analyzed, and time-dependent ROC curves were generated. The AP003696.1 target gene (lncRNA ENSG00000253385.1) was further investigated through immune infiltration analysis, Gene Ontology/Kyoto Encyclopedia of Genes and Genomes (GO/KEGG) enrichment analyses, and gene coexpression analysis. Finally, in vitro functional assays based on lncRNA ENSG00000253385.1 were conducted to explore its regulatory role in esophageal cancer. Results: A bioinformatics approach was used to study the eight genes in the necroptosis-related lncRNA risk model. AP003696.1 (lncRNA ENSG00000253385.1) was highly expressed in esophageal cancer tissues, and its high expression was correlated with poor OS and DFdS. Both univariate and multivariate Cox regression analyses revealed that lncRNA ENSG00000253385.1 is an independent prognostic factor. The lncRNA ENSG00000253385.1 gene was demonstrated to play a definite role in the invasion of esophageal cancer immune cells and in signaling pathways in these cells. In vitro cell functional assays revealed that lncRNA ENSG00000253385.1 expression was elevated in the KYSE150 and KYSE410 esophageal cancer cell lines. Small interfering RNA (siRNA)-mediated silencing of lncRNA ENSG00000253385.1 significantly inhibited the proliferation, migration, and invasion of KYSE150 and KYSE410 cells, as well as promoted their apoptosis. Conclusions: The ENSG00000253385.1 gene may be a key gene in the occurrence, development, and prognosis of esophageal cancer. These findings provide new ideas and references for the screening of therapeutic targets, as well as the development of targeted drugs, for esophageal cancer treatment.

LncRNA expression in idiopathic achalasia: New insight and preliminary exploration into pathogenesis

Gene Expression Dysregulated of Long Chain Non-coding RNA in Patients with Idiopathic Achalasia: New Insight into Pathogenesis

RNA-sequencing reveals molecular and regional differences in the esophageal mucosa of achalasia patients

A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia

Imbalance of Innate and Adaptive Immunity in Esophageal Achalasia.

Association of circulating cytokine levels and tissue-infiltrating myeloid cells with achalasia: results from Mendelian randomization and validation through clinical characteristics and single-cell RNA sequencing

Exploring the Neural Mechanisms Underlying Achalasia: A Study of Functional Connectivity and Regional Brain Activity.

A Cross‐sectional Study Reveals a Chronic Low‐grade Inflammation in Achalasia

The molecular pathogenesis of achalasia: a paired lower esophageal sphincter muscle and serum 4D label-free proteomic study

Multiplex immunoassays reveal increased serum cytokines and chemokines associated with the subtypes of achalasia

INPP4B overexpression and c-KIT downregulation in human achalasia

Docking Proteins Upregulate IL-1β Expression in Lower Esophageal Sphincter Muscle in Esophageal Achalasia

Mast Cell Infiltration Associated with Loss of Interstitial Cells of Cajal and Neuronal Degeneration in Achalasia

Achalasia: The Current Clinical Dilemma and Possible Pathogenesis

The Etiology Of Achalasia: An Immune-Dominant Disease

The NONRATT023402.2/rno-miR-3065-5p/NGFR Axis Affects Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Whole-exome sequencing reveals common and rare variants in immunologic and neurological genes implicated in achalasia

Comprehensive expression, prognostic and validation analysis of necroptosis-related lncRNAs in esophageal cancer

The Role of Type II Esophageal Microbiota in Achalasia: Activation of Macrophages and Degeneration of Myenteric Neurons

Association of a Newly Identified Lncrna LNC_000280 with the Formation of Acetylcholine Receptor Clusters in Vitro

Identification of Crucial Long Non-Coding RNAs and Mrnas along with Related Regulatory Networks Through Microarray Analysis in Esophageal Carcinoma